A framework to analyse gender bias in epidemiological research

Journal of Epidemiology and Community Health

Volumn 61, Issue SUPPL. 2, 2007, Pages

  Ruiz Cantero, María Teresa ^a,b,h   Vives Cases, Carmen ^a,b,h   Artazcoz, Lucía ^b,c,h   Delgado, Ana ^d   Calvente, Maria Del Mar García ^b,d   Miqueo, Consuelo ^e   Montera, Isabel ^b,f   Ortiz, Rocío ^a   Ronda, Elena ^a   Ruiz, Isabel ^b   Valls, Carme ^b,g  

^a UNIVERSITY OF ALICANTE   (Spain)

^b MINISTERIO DE SANIDAD Y CONSUMO   (Spain)

^c Agencia de Salud Publica de Barcelona   (Spain)

^d ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^e UNIVERSITY OF ZARAGOZA   (Spain)

^f UNIVERSITY OF VALENCIA   (Spain)

^g Centro de Análisis Y Planificación Sanitaria   (Spain)

^h CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DESIGN; EPIDEMIOLOGY; GENDER ISSUE; MEASUREMENT METHOD; RESEARCH; SAMPLING BIAS; WOMENS HEALTH;

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH CARE; HEALTH CARE SYSTEM; HUMAN; MALE; MEN'S HEALTH; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SEXISM; SOCIAL SUPPORT; WOMEN'S HEALTH;

EID: 36749079968     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.2007.062034     Document Type: Article

References (51)

1. Oakley A. Experiments in knowing. Gender and method in the social sciences. Cambridge: Polity Press, 2000.
2. Lenhart Sh. Gender discrimination: A health and career development problem for women physicians. J Am Med Women Assoc 1993;48:155-9.
3. Harding S. The science question in feminism. New York: Cornell University Press, Ithaca, 1993.
4. Harding S. Feminism and methodology: social science issues. Bloomington, IN: Indiana University Press, 1987.
5. Harding S. Whose science, whose knowledge? New York: Cornell University Press Ithaca, 1991.
6. Chapman KR, Tashkin D, Pye DJ. Gender bias in the diagnosis of COPD. Chest 2001;119:1691-5.
7. Miravitlles M, de la Roza C, Naberan K, et al. Altitudes toward the diagnosis of chronic obstructive pulmonary disease in primary care. Arch Bronconeumol 2006;42:3-8.
8. Doyal L. Sex and gender: the challenges for epidemiologists. Int J Health Serv 2003;33:569-79.
9. Miqueo C. Women and doctors in medicine. Lancet 1999;354:65.
10. Miqueo C, Barral MJ, Fernandez T, et al. Progresividad del proyecto género en salud. Análisis bibliométrico de la literatura internacional: 1982-2002. In: Pérez Sedeño E, ed. Ciencia, tecnología y género en Iberoamerica. Madrid: CSIC, 2006.
11. Ruiz MT, Verbrugge L. A two way view of gender bias in medicine. J Epidemiol Comm Health, 1997;51:106-9.
12. Eichler M. Non-sexist research methods. A practical guide. New York: Routledge, 1991.
13. Kotkamp-Mothes N, Slawinsky D, Hinderman S, et al. Coping and psychological well being in families of elderly cancer patients. Crit Rev Oncol Hematol 2005;55:213-29.
14. Van der Wal JF, Hoogeveen AW, Moons AMM, et al. Investigation on the exposure of hairdressers to chemical agents. Environ Int 1997;23:433-9.
15. Labreche F, Forest J, Trottier M, et al. Characterization of chemical exposures in hairdressing salons. Appl Occup Environ Hyg 2003;18:1014-21.
16. Gandhi M, Aweeka F, Greenblatt R, et al. Sex differences pharmacokinetics and pharmacodynamics. Annu Rev Pharmacol Toxicol 2004;44:499-523.
17. European Medicines Agency. Gender considerations in the conduct of clinical trials (EMEA/CHMP/3916/2005). http://www.emea.eu.int/pdfs/ human/ich/391605en.pdf (accessed 9 July 2007).
18. Rochon PA, Clark JP, Binns MA, et al. Reporting of gender-related information in clinical trials of drug therapy for myocardial infarction. CMAJ 1998;159:321-7.
19. Fleish J, Fleish M, Thürmann P. Women in early-phase clinical drug trials. Have things changed over the past 20 years? Clin Pharmacol Ther 2005;78:445-52.
20. Cascales S, Ruiz Cantero MT, Pardo MA. Clinical trials with rofecoxib: analysis of the information from the gender perspective. Med Clin (Barc) 2003;120:207-12.
21. Ruiz Cantero MT, Pardo MA. European Medicines Agency policies for clinical trials leave women unprotected. J Epidemiol Comm Health 2006;60:911-3.
22. Vidaver RM, LaFleur B, Tong C, et al. Women subjects in NHI-funded clinical research literature: lack of progress in both representation and analysis by sex. J Womens Health Gend Based Med 2000;9:495- 504.
23. Hoek HW, Van Hoeken D. Review of the prevalence and incidence of eating disorders. Int J Eat Disord 2003;34:383-96.
24. Peláez-Fernández MA, Labrador-Encinas FJ, Raich-Escursell RM. Epidemiología de los trastornos de la conducta alimentaria en España: revisión y estado de la cuestión. C Med Psicosom 2004;71-72:33-41.
25. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington: APA, 1994.
26. Machado PP, Machado BC, Goncalvez S, et al. The prevalence of eating disorders not otherwise specified. Int J Eat Disord 2007;40:212-21.
27. Hembree EA, Foa EB. Post-traumatic stress disorder: psychological factors and psychosocial interventions. J Clin Psychiatry 2000;61(suppl 7):33-99.
28. Breslau N, Davis GC, Andreski P, et al. Sex differences in post-traumatic stress disorder. Arch Gen Psvchiatry 1997;54:1044- 8.
29. Mechanic MB. Beyond PTSD: mental health consequences of violence against women. J Interpers Violence 2004;19:1283-9.
30. Norris FH. Epidemiology of trauma: frequency and impact of different potentially traumatic events on different demographic groups. J Consult Clin Psychol 1992;60:409-18.
31. Hastka J, Laserre JJ, Schwarzbeck A, et al. Laboratory tests of iron status: correlation or common sense? Clin Chem 1996;42:657.
32. Rushton DH, Dover R, Sainsbury AW, et al. Iron deficiency is neglected in women's health. BMJ 2002;325:1176.
33. Naghii MR, Fouladi AI. Correct assessment of iron depletion and iron deficiency anemia. Nutr Health 2006;18:133-9.
34. Hillman RS, Finch CA. Red cell manual. Philadelphia: Davis, 1996.
35. Kasper DL, Braunwald E, Fauci A, et al. Harrison's principles of internal medicine. New York: McGraw-Hill, 2004.
36. Takakuwa KM, Shofer FS, Hollander JE. The influence of race and gender on time to initial electrocardiogram for patients with chest pain. Acad Emerg Med 2006;13:867-72.
37. Rosenfeld AG, Lindauer A, Darney BG. Understanding treatment-seeking delay in women with acute myocardial infarction: descriptions of decision-making patterns. Am J Crit Care 2005;14:285-93.
38. Meischke H, Larsen MP, Eisenberg MS. Gender differences in reported symptoms for acute myocardial infarction: impact on prehospital delay time interval. Am J Emerg Med 1998;16:363-6.
39. Segura A, Zurriaga O, Rohlfs I, et al. Diferencias por género en las características, manejo y letalidad-complicaciones en pacientes con infarto agudo de miocardio (IAM): Estudio IBERICA. Gac Sanit 2002;16(Suppl 1):90.
40. Ruiz MT, Ronda E, Gil VF, et al. Atención según el género del paciente en los servicios de urgencias: ¿diferente o desigual? Gac Sanit 1995;9:76-83.
41. Stephenson P, McKee M. Look twice. Eur J Publ Health 1993;3:151-2.
42. Annandale E, Hunt K. Gender inequalities in health. Buckingham: Open University Press, 2000.
43. Artazcoz L, Borrell C, Benach J. Gender inequalities in health among workers: the relation with family demands. J Epidemiol Comm Health 2001;55:639-47.
44. Kunkel SR, Atchely RC. Why gender matters: being female is not the same as not being male. Am J Prev Med 1996;12:294-6.
45. Ruiz-Perez I, Plazaola-Castaño J, Blanco-Prieto P, et al. Intimate partner violence. A survey conducted in the primary care setting. Gac Sanit 2006;20:202-8.
46. Waltermaurer E, Ortega C, McNutt L. Issues in estimating the prevalence of intimate partner violence. Assessing the impact of abuse status on participation bias. J Interpers Violence 2003;18:959-74.
47. Strauss MA, Hamby SL, Boney-McCoy S, et al. The revised conflict tactics scales (CTS2). Development and preliminary psychometric data. J Fam Issues 1996;17:283-316.
48. Heise L. Violence against women. An integrated, ecological framework. Violence Against Women 1998;4:262-90.
49. Murphy JF, Dauncey M, Newcombe R. Employment in pregnancy: prevalence, maternal characteristics, perinatal outcome. Lancet 1984;26:1163-6.
50. Regidor E, Ronda E, García AM, et al. Paternal exposure to agriculture pesticides ana cause specific of foetal death. J Occup Environ Med 2004;61:334-9.
51. Ronda E, Regidor E, García AM, et al. Association between congenital anomalies and paternal exposure to agriculture pesticides depending on mother's employment status. J Occup Environ Med 2005;47:826-8.